News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Anavex Life Sciences Corp. Announces Its Preclinical Pipeline Of Novel Oncology Therapies
February 12, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
KELOWNA, BRITISH COLUMBIA -- (MARKET WIRE) -- February 12, 2007 -- Anavex Life Sciences Corp. (the "Company") (OTCBB: AVXL) announces its strategic vision for growth by discovering and developing cutting-edge drugs against solid tumors.
Twitter
LinkedIn
Facebook
Email
Print
Preclinical
Anavex Life Sciences Corp.
MORE ON THIS TOPIC
Obesity
Wave Stock Cut in Half on Underwhelming Higher Dose Obesity Data
March 26, 2026
·
2 min read
·
Tristan Manalac
Rare diseases
Beam’s Base Editor Advances to Pivotal Development on Back of ‘Impressive’ AATD Data
March 26, 2026
·
1 min read
·
Tristan Manalac
Pipeline
Sarepta Pushes Past Gene Therapy Debacle as RNA Therapies Show Early Promise
March 26, 2026
·
2 min read
·
Tristan Manalac
Insights
Beyond Buzzwords in Longevity Investing
March 26, 2026
·
1 min read
·
Jennifer C. Smith-Parker
